Study shows GLP-1 receptor agonists and GIP drugs reduce alcohol and opioid addiction by 50% and 40%, respectively.

A study published in the journal Addiction indicates that weight loss and diabetes medications, specifically GLP-1 receptor agonists like Ozempic and GIP drugs like Mounjaro, may help reduce alcohol and opioid addiction. Researchers found a 50% decrease in alcohol intoxication and a 40% reduction in opioid overdose among users of these medications. The findings suggest further investigation into their potential as treatment options for substance use disorders is warranted.

5 months ago
99 Articles